Fenoverine

Fenoverine
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	A03AX05 (WHO) ;
Identifiers
	IUPAC name 2-[4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl]-1-(10H-phenothiazin-10-yl)ethanone;
CAS Number	37561-27-6;
PubChem CID	72098;
ChemSpider	65083;
UNII	N274ZQ6PZJ;
KEGG	D07095 ;
ChEMBL	ChEMBL1512949;
CompTox Dashboard (EPA)	DTXSID8046296 ;
ECHA InfoCard	100.048.666
Chemical and physical data
Formula	C26H15N3O3S
Molar mass	449.48 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CN(CCN1CC2=CC3=C(C=C2)OCO3)CC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64;
	InChI InChI=1S/C26H25N3O3S/c30-26(29-20-5-1-3-7-24(20)33-25-8-4-2-6-21(25)29)17-28-13-11-27(12-14-28)16-19-9-10-22-23(15-19)32-18-31-22/h1-10,15H,11-14,16-18H2; Key:UBAJTZKNDCEGKL-UHFFFAOYSA-N;
	(verify)

Fenoverine (INN) is an antispasmodic [also known as spasmolytics] drug,^[1] which acts by inhibiting calcium channels^[2] [much in the same way as traditional calcium channel blockers, which are used as antianginal drugs]. In the case of Fenoverine, the relaxation occurs in abdominal / intestinal smooth muscles, while in case of antianginal drugs, the relaxation occurs in coronary vessels. Notably Fenoverine does not act as an antianginal agent.

Toxicity

Fenoverine is known to cause rhabdomyolysis.^[2]^[3]

References

[1]

[2]

[3]